Hillsdale Investment Management Inc. Nevro Corp Transaction History

Hillsdale Investment Management Inc.

  • $1.13 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$138.17 - $184.34 $1.02 Million - $1.36 Million
-7,400 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$114.09 - $145.51 $159,726 - $203,714
1,400 Added 23.33%
7,400 $1.03 Million
Q2 2020

Aug 11, 2020
SELL
$89.45 - $129.85 $2.17 Million - $3.16 Million
-24,300 Reduced 80.2%
6,000 $717,000
Q1 2020

May 12, 2020
BUY
$70.23 - $144.31 $2.13 Million - $4.37 Million
30,300 New
30,300 $3.03 Million

Others Institutions Holding NVRO

# of Institutions
173
Shares Held
37.4M
Call Options Held
80.4K
Put Options Held
898K
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $305M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email